It was reported that LINC00346 acts as an oncogenic, was overexpressed in breast cancer cells and that it exerts its oncogenic ability via the upregulation of GLUT1, thereby promoting breast cancer development [37]. The gene discussed is SLC2A1; the disease is breast cancer.